IPO Boutique

Morphic Holding, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Morphic Holding, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Morphic Holding, Inc.MORF -
NASDAQ
$14.00-$16.00 $15.00 $18.006 million6/27/2019
Jefferies, Cowen, BMO Capital Markets, Wells Fargo Securities
Co-Manager(s):
Health Care
Filing(s):

Filed 2019-05-30
Terms Added 2019-06-14



Morphic Holding, Inc. Quote & Chart - Click for current quote - MORF

About Morphic Holding, Inc. (adapted from Morphic Holding, Inc. prospectus):
They are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "MORF" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved